TRAVERE THERAPEUTICS INC TVTX 深 滬
交易中 09-19 12:39:06 美东时间
15.06
+0.710
+4.95%
華盛通- 最 高15.16
- 今 開14.69
- 成交量 57.90万股
- 最 低 14.44
- 昨 收 14.35
- 總市值 11.30亿
- 52周最高 15.16
- 市盈率 靜 --
- 換手率 0.77%
- 52周最低 5.12
- 委 比 20.00%
- 總股本 7501.09万
- 歷史最高 37.04
- 量 比 0.54
- 振 幅 5.02%
- 歷史最低 0.90
- 每 手 1
- 風險率 1.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 多只医药股狂飙！生物制药公司SMMT飙升56%，TVTX大涨17%
多只医药股狂飙！生物制药公司SMMT飙升56%，年内累涨633%，公司肺癌新药临床试验结果优异；TVTX大涨17%，公司的肾病药物获得FDA完全批准>>
09-10 16:11
Travere(TVTX.US)“first-in-class”疗法获FDA完全批准 显著减缓肾功能下降
9月7日，Travere Therapeutics(TVTX.US)宣布，美国FDA完全批准“first-in-class”疗法Filspari(sparsentan)。
09-07 15:37
Citigroup Maintains Buy on Travere Therapeutics, Raises Price Target to $23
Citigroup analyst Carly Kenselaar maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises the price target from $14 to $23.
09-07 02:47
NIO To Rally Around 65%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-06 20:16
Positive Outlook for Travere Therapeutics with Sparsentan’s Endorsement and Anticipated FDA Approval
Travere Therapeutics (TVTX – Research Report), the Healthcare sector company, w...
08-31 00:55
Novartis gets FDA approval for Fabhalta in IgAN patients
Novartis (NYSE:NVS) has received FDA accelerated approval for its drug Fabhalta to be used in the reduction of proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapi...
08-08 04:57
Expert Ratings For Travere Therapeutics
4 analysts have expressed a variety of opinions on Travere Therapeutics (NASDAQ...
08-02 22:00
Travere Therapeutics files for mixed shelf offering
Travere Therapeutics (NASDAQ:TVTX) on Thursday said that it filed a prospectus for a mixed shelf offering, with the size undisclosed. The prospectus is not an offer to sell. SEC Filing. More on Traver...
08-02 05:47
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on T...
07-09 22:05
Travere Therapeutics Shareholders Back Management and Growth Plan
Travere Therapeutics (TVTX) has provided an announcement. During the Annual Mee...
05-14 04:25
